Comparison of Hospitals Represented in 2017 Baseline Adult and Pediatric SAAR Referent Populations, Hospitals Reporting at Least 1 Month of Data to the NHSN Antimicrobial Use Option From a SAAR-Eligible Location, and Hospitals Enrolled in NHSN With at Least 1 Active SAAR-Eligible Location, as of February 2020
| . | Hospitals in Adult and/or Pediatric SAAR Referent Populationa (n = 457) . | Hospitals Reporting ≥1 Month of AU Option Data From SAAR-Eligible Locationb (n = 1511) . | Hospitals Enrolled in NHSN With ≥1 Active SAAR-Eligible Locationc (n = 4668) . |
|---|---|---|---|
| Facility type, no. hospitals (%) | |||
| General acute care | 320 (70.0) | 1172 (77.6) | 3378 (72.4) |
| Veterans Affairs | 75 (16.4) | 109 (7.2) | 117 (2.5) |
| Critical access | 28 (6.1) | 134 (8.9) | 893 (19.1) |
| Military | 19 (4.2) | 46 (3.0) | 49 (1.1) |
| Children’s | 6 (1.3) | 27 (1.8) | 81 (1.7) |
| Women’s and children’s | 4 (0.9) | 7 (0.5) | 15 (0.3) |
| Surgical | 3 (0.7) | 9 (0.6) | 111 (2.4) |
| Oncology | 1 (0.2) | 3 (0.2) | 18 (0.4) |
| Women’s | 1 (0.2) | 4 (0.3) | 6 (0.1) |
| Teaching status,d no. hospitals (%) | |||
| None | 131 (28.7) | 428 (28.3) | 2098 (44.9) |
| Undergraduate | 71 (15.5) | 250 (16.5) | 742 (15.9) |
| Graduate | 104 (22.8) | 258 (17.1) | 647 (13.9) |
| Major | 151 (33.0) | 575 (38.1) | 1181 (25.3) |
| Hospital bed size, no. hospitals (%) | |||
| 1–50 beds | 70 (15.3) | 288 (19.1) | 1679 (36.0) |
| 51–200 beds | 180 (39.4) | 579 (38.3) | 1628 (34.9) |
| 201–500 beds | 178 (38.9) | 507 (33.6) | 1119 (24.0) |
| >500 beds | 29 (6.3) | 137 (9.1) | 242 (5.2) |
| Other characteristics, median (IQR) | |||
| Total number of beds | 177 (86, 305) | 164 (73, 306) | 99 (28, 226) |
| Number of ICU beds | 20 (10, 42) | 18 (8, 46) | 10 (2, 29) |
| % of ICU beds among all bedse | 13.2 (8.9, 17.9) | 12.7 (8.0, 18.1) | 10.5 (4.6, 16.0) |
| Average hospital length of stayf | 4.3 (3.4, 5.0) | 4.1 (3.3, 5.0) | 4.0 (3.1, 4.9) |
| . | Hospitals in Adult and/or Pediatric SAAR Referent Populationa (n = 457) . | Hospitals Reporting ≥1 Month of AU Option Data From SAAR-Eligible Locationb (n = 1511) . | Hospitals Enrolled in NHSN With ≥1 Active SAAR-Eligible Locationc (n = 4668) . |
|---|---|---|---|
| Facility type, no. hospitals (%) | |||
| General acute care | 320 (70.0) | 1172 (77.6) | 3378 (72.4) |
| Veterans Affairs | 75 (16.4) | 109 (7.2) | 117 (2.5) |
| Critical access | 28 (6.1) | 134 (8.9) | 893 (19.1) |
| Military | 19 (4.2) | 46 (3.0) | 49 (1.1) |
| Children’s | 6 (1.3) | 27 (1.8) | 81 (1.7) |
| Women’s and children’s | 4 (0.9) | 7 (0.5) | 15 (0.3) |
| Surgical | 3 (0.7) | 9 (0.6) | 111 (2.4) |
| Oncology | 1 (0.2) | 3 (0.2) | 18 (0.4) |
| Women’s | 1 (0.2) | 4 (0.3) | 6 (0.1) |
| Teaching status,d no. hospitals (%) | |||
| None | 131 (28.7) | 428 (28.3) | 2098 (44.9) |
| Undergraduate | 71 (15.5) | 250 (16.5) | 742 (15.9) |
| Graduate | 104 (22.8) | 258 (17.1) | 647 (13.9) |
| Major | 151 (33.0) | 575 (38.1) | 1181 (25.3) |
| Hospital bed size, no. hospitals (%) | |||
| 1–50 beds | 70 (15.3) | 288 (19.1) | 1679 (36.0) |
| 51–200 beds | 180 (39.4) | 579 (38.3) | 1628 (34.9) |
| 201–500 beds | 178 (38.9) | 507 (33.6) | 1119 (24.0) |
| >500 beds | 29 (6.3) | 137 (9.1) | 242 (5.2) |
| Other characteristics, median (IQR) | |||
| Total number of beds | 177 (86, 305) | 164 (73, 306) | 99 (28, 226) |
| Number of ICU beds | 20 (10, 42) | 18 (8, 46) | 10 (2, 29) |
| % of ICU beds among all bedse | 13.2 (8.9, 17.9) | 12.7 (8.0, 18.1) | 10.5 (4.6, 16.0) |
| Average hospital length of stayf | 4.3 (3.4, 5.0) | 4.1 (3.3, 5.0) | 4.0 (3.1, 4.9) |
Abbreviations: AU, antimicrobial use; ICU, intensive care unit; IQR, interquartile range; NHSN, National Healthcare Safety Network; SAAR, Standardized Antimicrobial Administration Ratio.
aHospitals included in adult and/or pediatric referent populations. All hospitals comprising the pediatric SAAR referent group also contribute to the adult SAAR referent group, except for 6 children’s hospitals and 2 women’s and children’s hospitals, which report from pediatric SAAR locations but not adult SAAR locations.
bHospitals ever-reporting at least 1 month of data to the AU Option from at least 1 SAAR-eligible location.
cNHSN facilities eligible to participate in the AU Option and eligible to receive 2017 baseline SAARs. To be included, hospitals must meet the following criteria: have at least 1 active SAAR-eligible location mapped to their facility, have an NHSN annual hospital survey completed within the past 2 years, be 1 of the 9 facility types represented in our 2017 baseline referent population.
dUndergraduate teaching: facility has a program for medical/nursing students only. Graduate teaching: facility has a program for postgraduate medical training (ie, residency and/or fellowships). Major teaching: facility has a program for medical students and postgraduate medical training.
eCalculated as total number of ICU beds divided by total number of beds, multiplied by 100.
fCalculated as total number of annual patient days divided by total number of annual admissions.
Comparison of Hospitals Represented in 2017 Baseline Adult and Pediatric SAAR Referent Populations, Hospitals Reporting at Least 1 Month of Data to the NHSN Antimicrobial Use Option From a SAAR-Eligible Location, and Hospitals Enrolled in NHSN With at Least 1 Active SAAR-Eligible Location, as of February 2020
| . | Hospitals in Adult and/or Pediatric SAAR Referent Populationa (n = 457) . | Hospitals Reporting ≥1 Month of AU Option Data From SAAR-Eligible Locationb (n = 1511) . | Hospitals Enrolled in NHSN With ≥1 Active SAAR-Eligible Locationc (n = 4668) . |
|---|---|---|---|
| Facility type, no. hospitals (%) | |||
| General acute care | 320 (70.0) | 1172 (77.6) | 3378 (72.4) |
| Veterans Affairs | 75 (16.4) | 109 (7.2) | 117 (2.5) |
| Critical access | 28 (6.1) | 134 (8.9) | 893 (19.1) |
| Military | 19 (4.2) | 46 (3.0) | 49 (1.1) |
| Children’s | 6 (1.3) | 27 (1.8) | 81 (1.7) |
| Women’s and children’s | 4 (0.9) | 7 (0.5) | 15 (0.3) |
| Surgical | 3 (0.7) | 9 (0.6) | 111 (2.4) |
| Oncology | 1 (0.2) | 3 (0.2) | 18 (0.4) |
| Women’s | 1 (0.2) | 4 (0.3) | 6 (0.1) |
| Teaching status,d no. hospitals (%) | |||
| None | 131 (28.7) | 428 (28.3) | 2098 (44.9) |
| Undergraduate | 71 (15.5) | 250 (16.5) | 742 (15.9) |
| Graduate | 104 (22.8) | 258 (17.1) | 647 (13.9) |
| Major | 151 (33.0) | 575 (38.1) | 1181 (25.3) |
| Hospital bed size, no. hospitals (%) | |||
| 1–50 beds | 70 (15.3) | 288 (19.1) | 1679 (36.0) |
| 51–200 beds | 180 (39.4) | 579 (38.3) | 1628 (34.9) |
| 201–500 beds | 178 (38.9) | 507 (33.6) | 1119 (24.0) |
| >500 beds | 29 (6.3) | 137 (9.1) | 242 (5.2) |
| Other characteristics, median (IQR) | |||
| Total number of beds | 177 (86, 305) | 164 (73, 306) | 99 (28, 226) |
| Number of ICU beds | 20 (10, 42) | 18 (8, 46) | 10 (2, 29) |
| % of ICU beds among all bedse | 13.2 (8.9, 17.9) | 12.7 (8.0, 18.1) | 10.5 (4.6, 16.0) |
| Average hospital length of stayf | 4.3 (3.4, 5.0) | 4.1 (3.3, 5.0) | 4.0 (3.1, 4.9) |
| . | Hospitals in Adult and/or Pediatric SAAR Referent Populationa (n = 457) . | Hospitals Reporting ≥1 Month of AU Option Data From SAAR-Eligible Locationb (n = 1511) . | Hospitals Enrolled in NHSN With ≥1 Active SAAR-Eligible Locationc (n = 4668) . |
|---|---|---|---|
| Facility type, no. hospitals (%) | |||
| General acute care | 320 (70.0) | 1172 (77.6) | 3378 (72.4) |
| Veterans Affairs | 75 (16.4) | 109 (7.2) | 117 (2.5) |
| Critical access | 28 (6.1) | 134 (8.9) | 893 (19.1) |
| Military | 19 (4.2) | 46 (3.0) | 49 (1.1) |
| Children’s | 6 (1.3) | 27 (1.8) | 81 (1.7) |
| Women’s and children’s | 4 (0.9) | 7 (0.5) | 15 (0.3) |
| Surgical | 3 (0.7) | 9 (0.6) | 111 (2.4) |
| Oncology | 1 (0.2) | 3 (0.2) | 18 (0.4) |
| Women’s | 1 (0.2) | 4 (0.3) | 6 (0.1) |
| Teaching status,d no. hospitals (%) | |||
| None | 131 (28.7) | 428 (28.3) | 2098 (44.9) |
| Undergraduate | 71 (15.5) | 250 (16.5) | 742 (15.9) |
| Graduate | 104 (22.8) | 258 (17.1) | 647 (13.9) |
| Major | 151 (33.0) | 575 (38.1) | 1181 (25.3) |
| Hospital bed size, no. hospitals (%) | |||
| 1–50 beds | 70 (15.3) | 288 (19.1) | 1679 (36.0) |
| 51–200 beds | 180 (39.4) | 579 (38.3) | 1628 (34.9) |
| 201–500 beds | 178 (38.9) | 507 (33.6) | 1119 (24.0) |
| >500 beds | 29 (6.3) | 137 (9.1) | 242 (5.2) |
| Other characteristics, median (IQR) | |||
| Total number of beds | 177 (86, 305) | 164 (73, 306) | 99 (28, 226) |
| Number of ICU beds | 20 (10, 42) | 18 (8, 46) | 10 (2, 29) |
| % of ICU beds among all bedse | 13.2 (8.9, 17.9) | 12.7 (8.0, 18.1) | 10.5 (4.6, 16.0) |
| Average hospital length of stayf | 4.3 (3.4, 5.0) | 4.1 (3.3, 5.0) | 4.0 (3.1, 4.9) |
Abbreviations: AU, antimicrobial use; ICU, intensive care unit; IQR, interquartile range; NHSN, National Healthcare Safety Network; SAAR, Standardized Antimicrobial Administration Ratio.
aHospitals included in adult and/or pediatric referent populations. All hospitals comprising the pediatric SAAR referent group also contribute to the adult SAAR referent group, except for 6 children’s hospitals and 2 women’s and children’s hospitals, which report from pediatric SAAR locations but not adult SAAR locations.
bHospitals ever-reporting at least 1 month of data to the AU Option from at least 1 SAAR-eligible location.
cNHSN facilities eligible to participate in the AU Option and eligible to receive 2017 baseline SAARs. To be included, hospitals must meet the following criteria: have at least 1 active SAAR-eligible location mapped to their facility, have an NHSN annual hospital survey completed within the past 2 years, be 1 of the 9 facility types represented in our 2017 baseline referent population.
dUndergraduate teaching: facility has a program for medical/nursing students only. Graduate teaching: facility has a program for postgraduate medical training (ie, residency and/or fellowships). Major teaching: facility has a program for medical students and postgraduate medical training.
eCalculated as total number of ICU beds divided by total number of beds, multiplied by 100.
fCalculated as total number of annual patient days divided by total number of annual admissions.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
